NovoCure (NASDAQ: NVCR)
NovoCure Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
NovoCure Company Info
Novocure's tumor-treating field devices use electric fields to disrupt the replication of cancer cells.
News & Analysis
Why NovoCure Stock Soared 18.3% This Week
Novocure announced encouraging results in a phase 3 trial for its TTFields therapy.
Why Novocure Stock Is Jumping Today
Novocure had good news mixed with some not-so-good news.
Is Novocure Stock a Buy?
The stock isn't far from its 52-week low.
Why Novocure Stock Was Sick Today
Investors weren't particularly pleased with the company's third-quarter performance.
3 Things About NovoCure That Smart Investors Know
Its cancer-treating device is struggling to find its market.
Down 31% in 1 Day, What's Next for NovoCure Stock?
It's entering a risky period, but it could persevere.
Why Novocure Stock Fell 24.4% This Week
Novocure announced a disappointing outcome from a phase 3 clinical trial for a key cancer treatment.
Is NovoCure's Stock Headed for a Free Fall?
It can be hard to find a reason to remain bullish on NovoCure.
Valuation
Podcast Episodes
Why NovoCure's Regulatory News Is a Huge Win for Investors
The cancer-focused medical-device maker received the go-ahead to enter a brand-new market. Here's why the news should make investors giddy.
2 Winners and 2 Losers in the Med Tech Market This Quarter
Medical devices can be ultra reliable, lucrative business, but there are plenty of ways for companies to blow it, too.
3 Medical Device Companies for Your Watchlist
Recurring revenue, monopolistic market positions, and returns that tend to beat even the risky biotechs tie these three together.
Earnings Transcripts
NovoCure (NVCR) Q4 2023 Earnings Call Transcript
NVCR earnings call for the period ending December 31, 2023.
NovoCure (NVCR) Q3 2023 Earnings Call Transcript
NVCR earnings call for the period ending September 30, 2023.
NovoCure (NVCR) Q2 2023 Earnings Call Transcript
NVCR earnings call for the period ending June 30, 2023.
NovoCure (NVCR) Q1 2023 Earnings Call Transcript
NVCR earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.